• Blood Cancer Research Partnership

    Participating Sites

    • Blood and Marrow Transplant Group of Georgia at Northside Hospital is a collaboration between The Blood and Marrow Transplant Group of Georgia (BMTGA) and Northside Hospital. The NSH-BMT Program is one of the largest clinical transplant programs in the United States, serving patients undergoing bone marrow/stem cell transplant therapy and providing primary leukemia treatment. NSH-BMT staff includes nationally recognized physicians, mid-level practitioners, nurses, coordinators, clinical BMT PharmD.’s, a dedicated health psychologist, nutritionists, physical therapists and ancillary specialists.
    • Colorado Blood Cancer Institute (CBCI) is a new program established by the expert physicians who have served Rocky Mountain Blood and Marrow Transplant Program patients for more than 15 years. CBCI was developed to provide state-of-the-art treatment for blood cancers such as leukemia, lymphoma and multiple myeloma. CBCI is a FACT-accredited program for both autologous and allogeneic transplants, performing related and unrelated donor transplants including cord blood transplants. CBCI conducts cutting edge clinical research, testing innovative treatments for patients with blood cancers and bone marrow diseases. Referral to a blood cancer specialist early after diagnosis allows for full evaluation of treatment options and the development of a treatment plan including access to approximately 50 clinical trials. The physicians and staff can discuss research studies to ensure that patients receive the most progressive therapies available.
    • Columbia Basin Hematology Oncology was founded in 1998 by Dr. Thomas Rado and Dr. Ruben Sierra. CBHO began participating in clinical trials in 2005 and became a network affiliate of Seattle Cancer Care Alliance in 2012. It is the first clinic in Washington State to receive ASCO's Quality Oncology Practice Initiative (QOPI®) certification in 2010. CBHO has a staff of 70 employees including 5 physicians and 5 nurse practitioners and will see over 18,000 Hematology & Oncology patients in 2013. CBHO is committed to serving our community by offering evidence based treatment to both oncology & hematology patients while giving patients access to cutting edge clinical trials.
    • Florida Cancer Affiliates/Ocala Oncology Ocala Oncology provides patients comprehensive care for a wide range of cancers and hematological disorders. This network allows them to offer patient the state-of-the-art medical oncology treatment formerly found only at academic or institutional centers. They provide this advanced treatment in the comfort of warm personal centers in the patient's own community. Ocala Oncology Center believes that research and clinical trials are an integral part of their efforts to provide cancer patients access to the latest therapy and treatment options. Their physicians and staff are focused on helping patients win the fight against cancer and they are committed to providing the therapies to win that fight.
    • Hematology-Oncology Associates of Northern New Jersey (HOANNJ) has spent over 30 years building our outstanding reputation for delivering the highest level of treatment and care for individuals with cancer and blood disorders. HOANNJ develop and implement treatment strategies customized to meet the needs of each individual patient. Many of their board-certified physicians hold positions in the American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH). Several have also been named Best Doctors in America and have been cited by New Jersey Monthly and New Jersey Life magazines as "Top Doctors" in New Jersey. In addition to offering the very latest in traditional therapies such as radiation and chemotherapy, we also integrate complementary medicine techniques, including relaxation therapy, guided imagery, meditation, yoga, massage and other mind/body modalities.
    • Maine Center for Cancer Medicine (MCCM) is a recognized leader in the treatment of cancer and blood disorders. As a private medical practice of 15 oncologists and hematologists, MCCM manages all aspects of patient treatment and care. MCCM partners with hospitals and treatment centers throughout Northern New England to ensure patients receive high quality, evidence-based care close to home. MCCM provides patients with a broad spectrum of cancer treatment options, including participation in national and local clinical trials. MCCM offices are located in Scarborough, Biddeford, Brunswick, and Sanford, Maine.
    • New York Oncology Hematology (NYOH) is the leading provider of community-based cancer care services in New York State’s capital region. The NYOH medical staff includes 35 board certified physicians who specialize in the care of patients with cancer (medical oncology and radiation oncology) and blood-related disorders (hematology). With a patient care team of more than 300 oncology certified nurses, pharmacists, laboratory technologists, radiation therapists and support personnel and seven, easy-access locations, NYOH is the renowned cancer care provider of choice for thousands of area residents. NYOH physicians include 5 dedicated Hematologists mostly centered at our office at Albany Medical Center, where it also provides an outpatient autologous bone marrow stem cell transplantation service.
    • Pacific Cancer Care has been a leading provider of oncology and hematology services for over 30 years. Previously known as Monterey Bay Oncology and Los Palos Oncology and Hematology, the group has grown to become the major provider of oncology and hematology services in Central California. PCC is a place where experienced physicians care for their patients with the support of highly skilled nurses and a dedicated staff. Equipped with all the latest advances, the PCC team offers patients a complete, comprehensive program across the continuum of care. PCC patients receive the best possible care, which is both personalized, comprehensive and advanced, in a caring environment that is close to home.
    • The Saint Francis/Mount Sinai Regional Cancer Center is one of the region’s leading cancer treatment centers, located on the campus of St. Francis Hospital, a 600-bed community teaching hospital in Hartford, CT. The 45,000 square foot Cancer Center opened in 1993, and houses radiation oncology, medical oncology, and hematology, along with a broad network of support services. Within the cancer center, the Lea Economos Hematology Center for Clinical Research includes 5 physicians whose clinical focus is patients with hematologic malignancies, with access to cutting edge technology and clinical trials sponsored by NCI cooperative groups, pharmaceutical companies, and academic partners. This care is provided by specialized nurses, midlevel providers, physicians and clinical navigators in a patient- and family-focused environment.
    • Virginia Piper Cancer Institute® at Abbott-Northwestern Hospital is a teaching hospital cancer program accredited by the Commission on Cancer of the American College of Surgeons. Patients and their families are the heart and soul of the Virginia Piper Cancer Institute. We believe that every patient deserves the best technology, from a compassionate staff, in an environment that is focused on their needs. Minnesota Oncology is affiliated with Virginia Piper Cancer Institute. It is a specialized medical group dedicated solely to the treatment of various cancers and blood disorders with over 65 providers. Our team of expert health care professionals combines current technology and treatment methods in medical oncology, hematology, gynecologic oncology and thoracic surgery with clinical research, genetic counseling and alternative therapies.
    • West Cancer Center is a community-based oncology practice located in Memphis, TN. For over 34 years, the dedicated physicians and staff at West Cancer Center have been providing the highest quality care and cutting edge therapies for their patients located in the Midsouth. Our multidisciplinary physician group is comprised of 35 specialists in medical oncology, hematology, gynecologic oncology, breast surgery, radiation oncology, endocrinology, diagnostic and interventional radiology, as well as pain and palliative care. The clinical research program has successfully conducted over 350 phase I – III clinical trials.
  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms